← Retour à la liste complète des publications

Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer.

El-Khoury V, Béland M, Schritz A, Kim SY, Nazarov PV, Gaboury L, Sertamo K, Bernardin F, Batutu R, Antunes L, Bennett CW, Faÿs F, Berchem G, Kim YJ

Proteome and Genome Research Unit, Department of Oncology, Luxembourg Institute of Health, 1 A-B Rue Thomas Edison, L-1445, Strassen, Luxembourg.

Distinguishing lung adenocarcinoma (ADC) from squamous cell carcinoma (SCC) has a tremendous therapeutic implication. Sometimes, the commonly used immunohistochemistry (IHC) markers fail to discriminate between them, urging for the identification of new diagnostic biomarkers.

Br. J. Cancer 2018;119(5):580-590.

Pubmed ID: 30078843

Suivez l'IRIC

Logo UdeM